SCHEMBL7884458

SCHEMBL7884458

CCN(CC)Cc1ccccc1COc1cccc2cc(C(=O)N(C)C(=N)N)[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
TP53 P04637 4/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 3/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 1/20 0.36
FLT3 P36888 2/20 0.35
LMNA P02545 3/20 0.34
PKM P14618 1/20 0.33
ALOX15 P16050 1/20 0.33
PARP15 Q460N3 1/20 0.33
PARP10 Q53GL7 1/20 0.33
THRB P10828 1/20 0.33
SCN9A Q15858 1/20 0.33
SLC1A5 Q15758 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877457 0.92 MEN1 (0.39) MAPTTP53MEN1KMT2AKDM4E
SCHEMBL7884782 0.89 MEN1 (0.40) MAPTTP53MEN1KMT2AKDM4E
SCHEMBL7873850 0.88 MAPT (0.39) MAPTTP53MEN1KMT2AALDH1A1
SCHEMBL7882405 0.87 GYS1 (0.39) MAPTTP53MEN1KMT2ALMNA
SCHEMBL7881174 0.85 LTB4R (0.35) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL7880033 0.83 FFAR1 (0.35) MEN1KMT2AFLT3LMNAPKM
SCHEMBL7877560 0.83 HTR1B (0.39) MAPTTP53KDM4EALDH1A1FLT3
Hydrochloric Acid SCHEMBL7877859 0.82 SRD5A2 (0.42) MAPTTP53LMNA
SCHEMBL7873802 0.81 MEN1 (0.46) MEN1KMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL7873765 0.81 MAPT (0.37) MAPTTP53MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed